Creative Planning
ENZ

Creative Planning’s Enzo Biochem, Inc. ENZ Stock Holding History

Creative Planning’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31
Closed – – 3808
2017
Q2 		$0 Hold
31
– – ﹤0.01% 4872
2017
Q1 		$0 Hold
31
– – ﹤0.01% 4948
2016
Q4 		$0 Hold
31
– – ﹤0.01% 4882
2016
Q3 		$0 Hold
31
– – ﹤0.01% 4764
2016
Q2 		$0 Hold
31
– – ﹤0.01% 4558
2016
Q1 		$0 Hold
31
– – ﹤0.01% 4570
2015
Q4 		$0 Sell
31
-200
-87% -$845 ﹤0.01% 4612
2015
Q3 		$1K Buy
+231
New +$701 ﹤0.01% 4172
2015
Q2 		– Sell
-200
Closed -$1K – 3118
2015
Q1 		$1K Hold
200
– – ﹤0.01% 4090
2014
Q4 		$1K Hold
200
– – ﹤0.01% 4019
2014
Q3 		$1K Buy
+200
New +$1.07K ﹤0.01% 3881

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Creative Planning's ENZ Position: Q3 2017 in Review

Creative Planning sold out of Enzo Biochem, Inc. (ENZ) in Q3 2017, closing a stake of 31 shares.

Creative Planning first reported a position in ENZ in Q3 2014 and held it in 11 quarters. The position peaked at $1K in Q3 2015. 116 funds tracked by Wall St. Rank hold ENZ as of Q3 2017.

  • Creative Planning reported no remaining Enzo Biochem, Inc. position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 31 Enzo Biochem, Inc. shares in Q3 2017.
  • Creative Planning first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 11 quarters.
  • Creative Planning's Enzo Biochem, Inc. position peaked at $1K in Q3 2015.
  • 116 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.